Journal of the American College of Cardiology > 2012 > 59 > 23 > 2058-2064
Viewpoint and Commentary
Reconciling the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) Trial With Previous Surrogate Endpoint Trials
Source
Abstract
Identifiers
journal ISSN : | 0735-1097 |
DOI | 10.1016/j.jacc.2012.01.045 |